INS and type 1 diabetes mellitus: Non-metabolic complications of the insulin pump therapy, such as infusion set problems, pump malfunction, and infusion site complications, are common [20], and are reported by almost two-thirds of CSII-treated people with T1D, emphasizing the need of continued education and medical training.